Catalyst Biosciences Inc
F:HGF2
Income Statement
Earnings Waterfall
Catalyst Biosciences Inc
Income Statement
Catalyst Biosciences Inc
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
21
N/A
|
7
-65%
|
1
-89%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(9)
|
(7)
|
(1)
|
|
| Gross Profit |
12
N/A
|
(0)
N/A
|
(0)
+90%
|
|
| Operating Income | ||||
| Operating Expenses |
(68)
|
(88)
|
(29)
|
|
| Selling, General & Administrative |
(16)
|
(19)
|
(17)
|
|
| Research & Development |
(52)
|
(69)
|
(12)
|
|
| Operating Income |
(57)
N/A
|
(88)
-55%
|
(29)
+67%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
1
|
0
|
1
|
|
| Non-Reccuring Items |
(1)
|
0
|
21
|
|
| Total Other Income |
1
|
(0)
|
0
|
|
| Pre-Tax Income |
(56)
N/A
|
(88)
-56%
|
(8)
+91%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(56)
|
(88)
|
(8)
|
|
| Net Income (Common) |
(56)
N/A
|
(88)
-56%
|
(8)
+91%
|
|
| EPS (Diluted) |
-43.98
N/A
|
-43.04
+2%
|
-3.92
+91%
|
|